Hollywood is officially on strike, and AI is one big reason. In fact, one AI

Five new supercomputers have entered top 10 on the TOP500 list, but none of them

Snazzy, innovative laptop designs are constantly evolving. Smartphones are ubiquitous and astonishingly capable. So where

SAVE 49%: Watch the MTV VMAs for free with ExpressVPN. A one-year subscription to ExpressVPN

Ferrari team principal Fred Vasseur has slammed the FIA and labelled Red Bull’s penalty last year for breaching the cost cap as a “big joke.” Red Bull, who have won the drivers’ title in the last two years and are on track to do so with Max Verstappen again this year, were found guilty of a minor financial overspend for 2021 and were handed a £6m fine and docked 10 per cent of their car development time. However, the penalty has had little impact on Red Bull’s progress having won all 12 races so far this year – and Christian Horner’s team have won 22 of the last 23 grands prix overall. Ex-Alfa Romeo chief Vasseur, who took over at Ferrari from Mattia Binotto before the start of this season, insists the punishment should have been a lot harsher on Red Bull. "A penalty like last year really isn’t severe. If it should be necessary again, such a penalty should be much heavier,” the Frenchman told Italian outlet La Gazzetta dello Sport. "You have to keep in mind that a technical advantage will translate into a sporting advantage. Therefore, the penalty should be sporting and not a fine. “In soccer, if you use a hand, it’s a penalty... they don’t give you a [non-sporting] penalty. “The deduction of 10 per cent wind tunnel time is a big joke. They have already done most of the work by then." Verstappen is currently on a win-streak of eight and can match Sebastian Vettel’s all-time record from 2013 of nine with victory at his home race next up in Zandvoort. Ferrari, meanwhile, have not won a race since Austria last year and are currently fourth in the Constructors’ Championship behind Red Bull, Mercedes and Aston Martin. F1 returns after the summer break next week with the Dutch Grand Prix (25-27 August). Read More F1 2023 mid-season awards: Best driver, worst race and biggest surprise Carlos Sainz interview: ‘All of us at Ferrari expected more – we haven’t done the best job’ ‘It was pretty wild’: F1 champion Max Verstappen learns how to drift ‘It was pretty wild’: F1 champion Max Verstappen learns how to drift ‘Incredible’ Norris backed for more podium success by Verstappen and Perez F1 2023 calendar: All 23 Grand Prix this year

Netflix Inc. and FPT Telecom stopped offering the Chinese romantic TV drama Flight to You in Vietnam after

Amy Schumer has opened up about the reason why she stopped taking Ozempic, as she urged celebrities to be honest about their weight loss. The 43-year-old actor and comedian appeared on Watch What Happens Live with Andy Cohen on Thursday (8 June), where she revealed that tried taking the type 2 diabetes drug Ozempic for weight loss last year. “Like a year ago, I tried it,” she told Cohen, before admitting that she stopped taking the FDA-approved medication because of its side effects. “I was one of those people that felt so sick and couldn’t play with my son,” Schumer explained, referring to her four-year-old son Gene, who she shares with husband Chris Fischer. “I was so skinny and he’s throwing a ball at me and [I couldn’t].” Although the Trainwreck star admitted that she was “immediately invested” before trying the drug, she ultimately decided that Ozempic wasn’t “livable” for her. However, Schumer did take a moment to call out celebrities who have been “lying” about taking the once-weekly antidiabetic injection for weight loss. “Everyone’s like: ‘Smaller portions,’” she joked. “Shut the f*** up. You’re on Ozempic, or one of those things.” Much like Ozempic, FDA-approved medications Wegovy and Mounjaro are also brand names for semaglutide – which work by mimicking a hormone that regulates appetite and creates the feeling of fullness. “Just stop,” Schumer added. “Just be real with the people.” The Inside Amy Schumer star even noted how she was open about undergoing liposuction for weight loss in January 2022. “When I got lipo, I was like, I got lipo,” she said. Ozempic, a once-weekly injection used for the treatment of type 2 diabetes, has skyrocketed in use after people were reportedly prescribed the diabetes medication as an “off-label” weight loss drug. Meanwhile, Wegovy and Mounjaro are once-weekly semaglutide injections specifically approved for the treatment of obesity and weight loss. There are many side effects of taking medications like Ozempic, Wegovy, and Mounjaro. According to the US Food and Drug Administration (FDA), the most common side effects of taking Wegovy include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, and digestive disorders. The FDA has also warned against more serious complications that can occur from using Wegovy or Mounjaro, such as the “potential risk of thyroid C-cell tumours,” pancreatitis, gallbladder problems, acute kidney injury, increased heart rate, and suicidal behaviour or thinking. Meanwhile, taking Ozempic can lead to possible thyroid tumours, including cancer, pancreatitis, changes in vision, and kidney and gallbladder problems. Amy Schumer isn’t the only celebrity to open up about taking certain medications for weight loss. Comedian Chelsea Handler previously revealed that she “didn’t know” she was on Ozempic because her doctor allegedly “hands it out to anybody”. During an appearance on Alex Cooper’s Call Her Daddy podcast in January, the Chelsea Lately star spoke candidly about the alleged widespread use of Ozempic in Hollywood and her concerns over its popularity. “So, my anti-ageing doctor just hands it out to anybody,” Handler claimed. “I didn’t even know I was on it. She said: ‘If you ever want to drop five pounds, this is good.’” She said she realised she was taking the type 2 diabetes drug for weight loss after feeling nauseous while at lunch with a friend, who was also on Ozempic. When her friend asked if Handler was taking the medication, which the comedian referred to as “semaglutide” during their conversation, her friend informed her Ozempic was simply a brand name for semaglutide. However, Handler said she stopped taking the medication after she realised what it was. “I’m not on it anymore. That’s too irresponsible,” she shared. “I’m an irresponsible drug user, but I’m not gonna take a diabetic drug. I tried it, and I’m not gonna do that. That’s not for me. That’s not right for me.” Read More Shapewear is booming, and body image experts are worried: ‘It’s really dangerous’ OnlyFans model Elle Brooke praised for ‘perfect’ response to Piers Morgan’s concerns about her career Prince Andrew ‘staying in Royal Lodge amid renovations in case he is evicted’ STI cases at record highs: 6 things everyone needs to know about sexually transmitted infections Men’s Health Week: How to talk about sensitive or ’embarrassing’ health issues Jonnie Irwin explains why he hasn’t told his sons about his terminal cancer

A father-of-three who was told he looked like “Casper the ghost” before being diagnosed with acute myeloid leukaemia (AML) and given three weeks to live, meaning he has planned his own Requiem Mass and funeral, has defied doctors’ expectations by outliving his prognosis by more than a year and said he is going to “keep fighting”. Dennis Blackman, 62, a former chartered building surveyor and carer who lives in Eltham, London, said he has always been active – playing rugby, lifting weights, and going to the gym at least three times a week. However this all changed when he suffered an unexpected stroke in 2015. His health deteriorated over the following years, he had a hip replacement at 58, and after experiencing symptoms of extreme exhaustion, cold hands, and muscle weakness in early 2022, his wife Sally, 62, a former flooring showroom manager, suggested he book a doctor’s appointment. After weeks of blood tests and blood transfusions in hospital and being told he looked like “Casper the ghost” because he was so pale, he underwent a bone marrow biopsy, and this led to the devastating news in March 2022 that he has AML – a type of blood cancer – and three weeks to live. Dennis told PA Real Life: “I just broke down and I had this unbelievable feeling of guilt because I said to the consultant: ‘What have I done wrong? How do I tell my children and wife?’ “It’s a huge burden to put on someone, to tell them that you’re dying and it’s going to be very quick. “We had many dark days, and every time I looked into my children’s eyes I just burst into tears… it was a very emotional period for all of us.” Dennis, who has lost 50kg (7st 9lbs) since his diagnosis, did not start chemotherapy until months later due to him being too weak, and in January 2023, he was told the chemotherapy was “not working any more”. From that point on, he said he wanted to “enjoy each day” rather than pursuing more aggressive forms of treatment – and since then, he has planned his own Requiem Mass with hymns such as How Great Thou Art and Ave Maria (As I Kneel Before You), as well as the arrangements for his funeral. Now, Dennis continues to drive, go shopping, and enjoy time with his family, and he said he is going to “keep fighting” during the time he has left as “you only have one life”. “Every day you go to bed and you think: ‘Am I going to wake up tomorrow?’ And then each morning you think: ‘Is it going to be today that I’m going to die?’” Dennis explained. “It was extremely difficult in the beginning and I tried to shut the world out… but as time went on, I realised you can’t live like this forever. “You only get one life, so I’m going to do everything I can to keep fighting.” During his 40s and early 50s, Dennis said he enjoyed going out for meals with his wife Sally, playing rugby with his sons James, 37, and Joe, 31, and keeping fit by going to the gym several times a week. He foresaw spending his days in retirement with his family, out in the garden, or fishing, but he said this all changed when he had a stroke in 2015, aged 54, and his health declined from then on. In early 2022, he spent six weeks at Queen Elizabeth Hospital in London after noticing some unusual symptoms and was told: “You look like Casper (the ghost), you’re very anaemic.” He then underwent several blood tests and blood transfusions, and although he had “an idea” that he may have cancer, he said he could never have prepared himself for his diagnosis on March 31 2022. “About one o’clock, I had a knock at the door and I thought: ‘That’s ominous’,” Dennis said. “The consultant and the specialist nurse came in and they said: ‘Unfortunately it’s bad news, you’ve got severe AML and there’s not a lot we can do at this stage.’ “’You’ve got three weeks to live, and I’d advise you to go home and tell your wife and family, and make sure everything’s in order because you haven’t got long left’.” Given Dennis has severe neutropenia as well – a low number of white blood cells – he is at a higher risk of contracting serious infections, and this meant he missed several family celebrations in the months that followed, including his grandson’s birthday party and stepdaughter’s wedding. He developed multiple chest infections and fevers and was not deemed fit enough to start chemotherapy straight away, and he ended up spending three months in hospital from July to October. “We thought we were going to lose him, he was so ill,” Sally, who has been married to Dennis for 10 years, explained. “Even the consultant thought we were going to lose him. “I was scared because I just thought: ‘How can this be happening when we’ve only just met each other?’ We just thought we were going to have the rest of our lives together.” However, Dennis, who is Catholic, said he “fought and prayed every day”, adding: “I said to the consultant: ‘If you promise to me you won’t give up on me medically, I promise I’ll fight this all the way.’” Dennis was determined to get better and, with the help of a physiotherapist, he built up his strength – and at one point, he was walking 10,000 steps a day along the hospital corridor. Towards the end of October 2022, Dennis said “everything seemed hunky dory” and he commenced the first of four rounds of chemotherapy, where he experienced nausea, exhaustion, and “tremendous leg bone pain”. By January, he was told the chemotherapy was “not working”, but rather than trying other forms of treatment, he said he wanted to “enjoy the little things” and the time he has left. He has planned his own Requiem Mass and funeral to relieve any pressure from his family, but also to give him “strength” and some control over his destiny – and aside from his regular check-ups and blood tests each week, he is setting himself small milestones, such as attending a Madness concert at the O2 in December. Although he is “struggling to survive”, he said he would do “anything to get another day” – and that is why he is holding onto hope and wants to encourage others never to give up. “Even though I pray every day, not once have I asked God to take it away from me – all I ask is that He’s with me when I need him, to give me the strength to carry on fighting,” he said. “Leukaemia is painful and every day I question whether I’ll see another day, but we just try and keep going and I hope that my story gives hope to others. “I’ve still got lots of memories to make yet, so I’m going to fight this all the way.” For more information and support, visit Leukaemia Care’s website at leukaemiacare.org.uk Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live One in 10 ‘spending beyond their means’ – try these 7 cutbacks guaranteed to save families money What is combination cholesterol therapy, as study suggests it could save lives? Cancer cases in young people ‘are rising’ – the warning signs to look out for

With new research emerging, more questions have been raised about weight-loss injections, how they work, and the risks involved. Here are some of your questions answered. What are weight loss injections? Championed by some celebrities, including Elon Musk, weight loss injections were originally created to treat people with type 2 diabetes and other weight-related health issues. They are a type of prescription-based medical treatment that interferes with your metabolism, regulates your appetite and as a result encourages weight loss. The drugs belong to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs, which mimic the GLP-1 hormone, released in the gut after eating some food. The only FDA-approved stomach injections to help with weight management are semaglutide — sold under the brand names Ozempic, Wegovy and Rybelsus — and liraglutide — sold under Saxenda. But others are in development. Helen Knight, programme director of the Centre for Health Technology Evaluation at the National Institute for Health and Care Excellence (Nice) said: “We know that management of overweight and obesity is one of the biggest challenges our health service is facing with nearly two-thirds of adults either overweight or obese. It is a lifelong condition that needs medical intervention, has psychological and physical effects, and can affect the quality of life. “But in recent years Nice has been able to recommend a new line of pharmaceutical treatments which have shown that those people using them, alongside changes to their diet and exercise, have been able to reduce their weight.” How do they work? According to Nice’s independent appraisal committee, drugs like semaglutide should only be prescribed to patients as an alternative for weight management — alongside a reduced-calorie diet and increased physical activity in adults. They should also have a BMI of at least 35.0 kg/m2 (this is medically classified as obese), and especially, to people with a BMI of 30.0 kg/m2 to 34.9 kg/m2, have non-diabetic hyperglycaemia (blood sugar that is above normal but below those needed to diagnose diabetes) or are at high risk of other weight-related conditions such as strokes and heart attacks, due to other factors such as high blood pressure and high cholesterol. Using semaglutide as an example, a typical dose for weight loss is 2.4 milligrams, administered weekly as under-the-skin self-injections. How are they going to be rolled out? Nice formally recommended liraglutide, orlistat and semaglutide as medicines suitable to use for weight loss earlier this year. And with such drugs also available through online pharmacies by private prescription, a growing number of people have tried the jabs. If they are prescribed alongside a reduced-calorie diet, increased physical activity, and behavioural support, after a year, people taking them can lose up to 15% of their body weight, with results visible within the first month, according to the Nice clinical trials. Some weight loss injections are available on the NHS, but they are only prescribed under certain circumstances. Following an announcement of a £40 million two-year pilot on June 7, the government have said more people living with obesity will have access to the newest and most effective obesity drugs to help cut NHS waiting lists. What are the possible side effects? Europe’s drug regulator The European Medicines Agency (EMA) is investigating whether patients using some weight loss and obesity jabs are at risk of suicidal thoughts and thoughts of self-harm, which highlights some of the controversy surrounding the phenomenon. The EMA safety committee said it is looking at cases among people who use a semaglutide or liraglutide-containing medicine for weight loss – where “signals” were raised by the Icelandic Medicines Agency. “A signal is information on a new or known adverse event that is potentially caused by a medicine and that warrants further investigation,” the EMA said. “The case reports included two cases of suicidal thoughts, one following the use of Saxenda and one after Ozempic. One additional case reported thoughts of self-injury with Saxenda. “The semaglutide-containing medicine Wegovy and the liraglutide-containing medicine Saxenda are authorised for weight loss, together with diet and physical activity. “Suicidal behaviour is not currently listed as a side-effect in the EU product information of these medicines.” If you have a history of medullary thyroid cancer, gallbladder disease, or even pancreatitis, you should avoid taking weight loss injections like semaglutide. People who do take the prescription drug for weight loss sometimes experience dizziness, fatigue, and gastrointestinal issues — the most common side effects among patients — such as diarrhoea, constipation and gassiness. They are also at risk of getting headaches and stomach conditions including vomiting, bloating and nausea. Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live Journalist and author Yomi Adegoke on the real-life consequences of social media What is group B strep? Charity says pregnant women ‘in the dark’ Britney Spears: I worked my ass off to get my memoir written

L’Oreal SA sales in the region that includes China unexpectedly fell in the third quarter as the cosmetics

If you’re cringing at the very thought of owning a Pixel phone, I’m right there

SAVE 49%: ExpressVPN is the top choice for unblocking streaming sites like ESPN+. A one-year